Stock Price & Analysis

Analysis and Insights

Based on the provided data, here's a concise analysis to help determine whether to buy or sell PX stock:

Technical Analysis:

PX stock is currently trading at $12.3, with a Fibonacci pivot point at $11.73, suggesting potential support. The RSI values (68.04, 54.04, 52.07) indicate the stock is not overbought, and the MACD (-0.21) is nearing a bullish crossover, signaling potential upward momentum.

Fundamental Analysis:

PX declared a consistent quarterly dividend of $0.035, maintaining stability. However, insider selling (60,000 shares) by a director raises concerns about internal confidence. Positively, 79 institutional investors increased their positions, indicating confidence in the stock's potential.

Valuation and Sentiment:

The stock is trading near its lower Bollinger Band, suggesting potential undervaluation. The 20-day SMA ($11.90) is below the current price, indicating short-term strength, while the 50-day SMA ($12.77) is above, showing medium-term resistance.

Conclusion:

Given the stock's position near support levels and mixed technical signals, it may be a buying opportunity if it bounces back. However, the insider selling and medium-term resistance are cautionary. Consider waiting for a bullish crossover or further positive news before making a decision.

The price prediction for PX stock in 2025 is $12.60. This forecast is based on technical analysis, where the stock is nearing a resistance level at 12.29. If it breaks above, it could target 12.63, supported by moderate RSI and moving averages.

The S1 support level for PX Stock is $11.57 ,The R1 resistant level for PX Stock is $12.33.

As of the end of day on 2025-03-31, the price of PX Stock was $11.75.

The target price for PX Stock according to analyst rating is 15.50, with the highest price target at 20.00 and the lowest at 13.00. Analysts have a Moderate Buy rating on PX Stock overall.

The market cap of PX is $1.3B.

PX appears overvalued based on its current valuation metrics and recent insider activity. Here's a concise analysis:

1. High Valuation Metrics: PX's PE ratio (22.67), EV/EBITDA (5.12), and PS ratio (4.04) are all elevated compared to industry averages, suggesting the stock may be overpriced.

2. Low Dividend Yield: The dividend yield of 1.09% is relatively low, indicating that investors are expecting capital appreciation rather than income, which can be risky if growth slows.

3. Insider Selling: Recent insider transactions show significant selling activity, which may reflect a lack of confidence in the stock's short-term prospects.

4. Institutional Interest: While 79 institutional investors have increased their positions, the high valuation metrics still pose a risk.

In conclusion, PX's high valuation and insider selling activity suggest it may be overvalued. Investors should exercise caution and consider whether the company's growth prospects justify the current price.

P10, Inc. is a multi-asset class private markets solutions provider in the alternative asset management industry. The Company provides its investors with differentiated access to a broad set of investment solutions that address their diverse investment needs within private markets. It structures, manages and monitors portfolios of private market investments, which include specialized funds and customized separate accounts within primary investment funds, secondary investments, direct investments and co-investments, (collectively, specialized investment vehicles) across asset classes and geographies in the middle and lower middle markets. Its portfolio of private solutions includes Private Equity, Venture Capital, Impact Investing and Private Credit. The Company has a global investor base of more than 3,600 investors across 50 states, 60 countries, and six continents, which includes pension funds, endowments, foundations, corporate pensions, and financial institutions, among others.

PX stock is predicted to reach $15.00 by 2030, driven by its stable dividend yield and increasing institutional investments. The stock currently trades at $12.06, with a median analyst target of $12.00, indicating moderate growth potential.

PX has a total of 252 employees.